Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Time to Sell?

Hypermarcas (OTCMKTS:HYPMY)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $4.85, but opened at $4.62. Hypermarcas shares last traded at $4.62, with a volume of 634 shares trading hands.

Hypermarcas Stock Down 6.5%

The company has a market cap of $3.02 billion, a PE ratio of 20.70 and a beta of 0.82. The firm has a 50-day simple moving average of $4.35 and a two-hundred day simple moving average of $4.45. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80.

Hypermarcas (OTCMKTS:HYPMY) last posted its quarterly earnings data on Wednesday, November 12th. The company reported $0.13 EPS for the quarter. Hypermarcas had a return on equity of 6.99% and a net margin of 12.03%.The business had revenue of $408.83 million for the quarter.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.